COMMUNIQUÉS West-GlobeNewswire

Acarix : Year-end Report, January - December 2017

26/02/2018 - 09:01

Press release Malmö, February 26, 2018 Year-end Report, January - December 2017 CADScor®System launched in key markets "In 2017, we achieved historic milestones in Acarix - most noticeably the receipt of our first [...]

INVITATION: Terveystalo Plc Full year 2017 result - Press conference and live webcast for analysts

26/02/2018 - 07:01

Terveystalo Plc will publish its Financial statements release 2017 on 28 February 2018 at approximately 9:00 a.m. Finnish time. The company will hold a press conference on 28 February, 2018, starting at 12:00 EET, at [...]

MediciNova to Present at the Cowen Health Care Conference in Boston

26/02/2018 - 00:00

LA JOLLA, Calif., Feb. 25, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

GIAPREZA™ (angiotensin II) Significantly Improved Survival of Patients with High APACHE II Scores in ATHOS-3 Study

25/02/2018 - 15:00

SAN DIEGO, Feb. 25, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) today announced that an abstract, entitled “ Effect of Disease Severity on Survival in Patients Receiving Angiotensin II for [...]

Agility Health Receives Conditional Approval from TSX Venture Exchange ("TSXV") for Proposed Transaction with Alliance

24/02/2018 - 03:24

GRAND RAPIDS, Mich., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“Agility Health” or the “Company”) announced today that it has received conditional approval from the TSXV for its previously [...]

Almost Family, Inc. to Report Fourth Quarter and Full Year 2017 Financial Results After Market Close on February 26, 2018

23/02/2018 - 23:45

LOUISVILLE, Ky., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Almost Family, Inc. (Nasdaq: AFAM ), a leading provider of home health nursing and personal care services, announced today that it will report financial results for its [...]

IRIDEX Issues Voluntary Recall of TruFocus LIO Premiere™ Laser Indirect Ophthalmoscope

23/02/2018 - 22:05

MOUNTAIN VIEW, Calif, Feb. 23, 2018 (GLOBE NEWSWIRE) -- On February 23, 2018 , IRIDEX Corporation (“Company”) initiated a voluntary recall of a specific laser accessory called the TruFocus LIO Premiere™. The LIO is a [...]

ObsEva SA to Hold Investor Call to announce Topline Results of the IMPLANT2 phase 3 Clinical Trial of Nolasiban in IVF/ICSI on Monday February 26, 2018

23/02/2018 - 22:00

Geneva, Switzerland and Boston, MA - February 23, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

Nobilis Therapeutics Presents Its PTSD Clinical Development Program To The US Congress

23/02/2018 - 21:19

WASHINGTON, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Dr. Edward Meloni, PhD of McLean Hospital (Harvard Medical School Affiliate) and Dr. Vlad Bogin, CEO and Founder of Nobilis Therapeutics earlier this week presented PTSD [...]

KemPharm Announces FDA Approval of Apadaz™ (benzhydrocodone and acetaminophen) for the Short-Term Management of Acute Pain

23/02/2018 - 20:00

Apadaz is the First Prodrug of Hydrocodone/Acetaminophen to be Approved by FDA Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 2:30 p.m. ET CORALVILLE, Iowa, Feb. 23, 2018 (GLOBE [...]

Nova Leap Health Corp. Closes Brokered and Non-Brokered Private Placements For $1.71 million

23/02/2018 - 18:52

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Novia Scotia, Feb. 23, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV:NLH) ("Nova Leap" or the "Company"), a [...]

New Study Uses Electronic Health Record Data to Identify Hypertension in Patients from Underserved Communities

23/02/2018 - 18:30

OAKBROOK TERRACE, Ill., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Although hypertension is the most common chronic condition among patients in health centers serving uninsured or underserved communities in the United States, [...]

Analogic Announces Timing for Second Quarter 2018 Earnings Conference Call and Webcast

23/02/2018 - 17:45

PEABODY, Mass., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ) announced today that it will conduct a conference call on Monday, March 5, 2018, at 5:00 p.m. (ET) to discuss results for the second [...]

Pascal Biosciences Inc. Announces Non-Brokered Private Placement

23/02/2018 - 17:14

VANCOUVER, British Columbia, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”) arranges a non-brokered private placement of up to 12,500,000 units (each a “Unit”) at a [...]

Medifirst Solutions Time Machine Laser to be Used in Sleep Apnea Program

23/02/2018 - 17:05

FREEHOLD, NJ, Feb. 23, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]

Latvijas Juras medicinas centrs JSC: Consolidated interim report for the 12 months of 2017.

23/02/2018 - 15:03

Latvia, 2018-02-23 15:03 CET (GLOBE NEWSWIRE) -- Latvijas Juras medicinas centrs JSC: Consolidated interim report for the 12 months of 2017, approved by the Board at 21.02.2018. Member of the Board: Juris Imaks, phone: [...]

INSYS Therapeutics to Report Fourth Quarter 2017 Results on March 8

23/02/2018 - 15:00

PHOENIX, Feb. 23, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]

Adamis Pharmaceuticals Updates Symjepi Commercialization Plans

23/02/2018 - 15:00

SAN DIEGO, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) today provided an update on the progress of exploring commercialization options relating to the commercial launch of its [...]

Kalytera Announces Further Issuance of Shares under Services Agreement with Salzman Group

23/02/2018 - 14:23

SAN FRANCISCO and TEL AVIV, Israel, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that the Company has elected to issue [...]